39 Singapore We are the largest private healthcare organisation in Singapore, known for our prominent brands that are trusted among local and regional healthcare consumers. We operate four hospitals - Gleneagles Hospital, Mount Elizabeth Hospital, Mount Elizabeth Novena Hospital and Parkway East Hospital. They provide close to 700 beds and over 1,500 top-tier clinical specialists across all specialties. IHH Singapore also services patients around the world via 35 remote patient assistance centres. Additionally, we manage Parkway MediCentre, IHH Singapore’s first ambulatory care centre; Parkway Shenton, a network of around 50 primary care clinics; and iXchange, which administers employee benefits plans. We also deliver specialty and ancillary care services via Parkway Cancer Centre, Parkway Radiology, Parkway Laboratories, Parkway Rehab and Parkway Emergency Services. Key Growth Areas • Enhanced expertise in complex care which drives revenue intensity • Expansion of services across the healthcare continuum by decanting lower acuity treatments out of the hospital, freeing up space for high acuity treatments Performance Indicators Financial FY2023 FY2024 Revenue RM5.6 billion RM6.1 billion EBITDA RM1.6 billion RM1.8 billion Operational Average Occupancy 61% 66% Inpatient admissions 61,197 61,909 Average revenue per inpatient admission RM54,994 RM61,528 Performance Highlights • Officially opened the Proton Therapy Centre at Mount Elizabeth Hospital in May 2024, advancing cancer treatment in the region. • Decanted some lower acuity treatments out of the hospital to nearby facilities, such as the Mount Elizabeth Fertility Centre (MEFC) at The Heeren, a facility adjacent to Mount Elizabeth Hospital. • Broke ground for TCF@East, IHH Singapore’s first transitional care facility. This step-down care facility will house 200 beds. • Launched Parkway Homecare to meet community needs via home medical, nursing, rehabilitation, dietetics and screening support. • Accelerated progress of Project Renaissance at Mount Elizabeth Hospital where renovation is expected to complete by Q3 2025, ahead of schedule. Several clinics have also reopened, such as Parkway Cancer Centre and the refreshed Radiologic Clinic which features new and upgraded machines. Outlook Leveraging the country’s well-established reputation as a medical hub for the region, we will continue to enhance our value proposition in Singapore through deeper expertise in complex care. For example, IHH Singapore introduced cutting-edge cancer treatments such as Proton Therapy and Hyperthermia therapy to further enhance its competitive strength in radiation oncology. As IHH Singapore continues to execute its ”out of hospital” strategy, it will add new ambulatory care facilities in Royal Square and Tong Building within the next few years. We seek to right-site our patients, decanting lower acuity treatments out of hospitals, allowing our hospitals to focus on higher acuity treatments. This allows us to enhance patient care while optimising operations. With Mount Elizabeth Hospital to be fully refreshed by late 2025, we look forward to providing elevated patient experience and clinical and operational standards. By increasing the accessibility and quality of our healthcare facilities in Singapore, IHH is also synchronous with Singapore’s national initiative of promoting healthy longevity,
RkJQdWJsaXNoZXIy NDgzMzc=